Chronic Platelet Activation and Acute Coronary Syndromes in 13 Middle-Aged Patients
| Autor: | Luciano Kolodny, Robert J. Myerberg, Michael D. Ozner, Lawrence L. Horstman, Wenche Jy, Yeon S. Ahn |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Heart disease business.industry Platelet disorder Hematology General Medicine 030204 cardiovascular system & hematology medicine.disease Gastroenterology Aged patients Middle age Immune thrombocytopenia 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Internal medicine Immunology Medicine Platelet Platelet activation business |
| Zdroj: | Clinical and Applied Thrombosis/Hemostasis. 3:46-53 |
| ISSN: | 1938-2723 1076-0296 |
| Popis: | We report on clinical, laboratory, and angiographic findings that appear to characterize a group of 13 middle-aged patients who suffered acute coronary syndromes (ACS) despite little angiographic evidence of atherosclerotic heart disease (ASHD) or other risk factors. Nine of the 13 were ≤46 years of age and the rest ranged to 59 years. All had evidence of platelet disorders (PD): seven had chronic immune thrombocytopenia (ITP), one had familial thrombocytopenia, and five had other disorders affecting platelets. Evidence of long-standing chronic platelet activation was the common feature of the group, as found by (i) elevated platelet microparticles (PMP), (ii) thrombocytopenia, and (iii) enhanced procoagulant activity of plasma. Data on the 7 with ITP were compared to 20 ITP without ACS: the former had higher PMP (p < 0.01) and platelet-associated IgM (p < 0.05) relative to the ITP patient controls. Another set of patient controls consisted of 20 ACS with documented ASHD: although activation indicators were abnormal also in this group relative to normal controls (p < 0.01), the PD group of 13 had more marked abnormalities in all tests (p < 0.03), particularly in PMP and thrombocytopenia (p < 0.01). The seven youngest in the PD group appeared to respond to antiplatelet therapy since no recurrence of coronary ischemia was seen in up to 3 years of observation. It is suggested that chronic platelet activation by antibodies or immune complex may predispose those in the PD group to ACS (e.g., when under stress) despite the absence of ASHD and few other known risk factors. The true incidence of this syndrome is unknown but may be substantial. Key Words: Chronic platelet activation-Platelet microparticles-Platelet.associated IgM-Immune thrombocytopenia-Acute coronary syndromes-Middle age. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|